#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=An abdominal aortic aneurysm ( AAA ) is a localized irreversible dilatation of the abdominal segment of the aorta , often due to a weakening of the wall of the vessel .
3-1	17-19	An	organization[4]	new[4]	appos	3-6[0_4]
3-2	20-29	abdominal	organization[4]	new[4]	_	_
3-3	30-36	aortic	abstract|organization[4]	new|new[4]	coref	3-18[8_0]
3-4	37-45	aneurysm	organization[4]	new[4]	_	_
3-5	46-47	(	_	_	_	_
3-6	48-51	AAA	organization	giv	coref	3-9[6_0]
3-7	52-53	)	_	_	_	_
3-8	54-56	is	_	_	_	_
3-9	57-58	a	organization[6]	giv[6]	coref	4-1[12_6]
3-10	59-68	localized	organization[6]	giv[6]	_	_
3-11	69-81	irreversible	organization[6]	giv[6]	_	_
3-12	82-92	dilatation	organization[6]	giv[6]	_	_
3-13	93-95	of	organization[6]	giv[6]	_	_
3-14	96-99	the	organization[6]|place[7]	giv[6]|new[7]	_	_
3-15	100-109	abdominal	organization[6]|place[7]	giv[6]|new[7]	_	_
3-16	110-117	segment	organization[6]|place[7]	giv[6]|new[7]	_	_
3-17	118-120	of	organization[6]|place[7]	giv[6]|new[7]	_	_
3-18	121-124	the	organization[6]|place[7]|abstract[8]	giv[6]|new[7]|giv[8]	coref	5-6[19_8]
3-19	125-130	aorta	organization[6]|place[7]|abstract[8]	giv[6]|new[7]|giv[8]	_	_
3-20	131-132	,	_	_	_	_
3-21	133-138	often	_	_	_	_
3-22	139-142	due	_	_	_	_
3-23	143-145	to	_	_	_	_
3-24	146-147	a	event[9]	new[9]	_	_
3-25	148-157	weakening	event[9]	new[9]	_	_
3-26	158-160	of	event[9]	new[9]	_	_
3-27	161-164	the	event[9]|object[10]	new[9]|new[10]	coref	11-14[0_10]
3-28	165-169	wall	event[9]|object[10]	new[9]|new[10]	_	_
3-29	170-172	of	event[9]|object[10]	new[9]|new[10]	_	_
3-30	173-176	the	event[9]|object[10]|object[11]	new[9]|new[10]|new[11]	coref	6-55[0_11]
3-31	177-183	vessel	event[9]|object[10]|object[11]	new[9]|new[10]|new[11]	_	_
3-32	184-185	.	_	_	_	_

#Text=An AAA refers to a diameter increase of at least 50 % compared to the normal arteria , which measures indicatively 2 cm .
4-1	186-188	An	organization[12]	giv[12]	coref	5-23[23_12]
4-2	189-192	AAA	organization[12]	giv[12]	_	_
4-3	193-199	refers	_	_	_	_
4-4	200-202	to	_	_	_	_
4-5	203-204	a	abstract[14]	new[14]	_	_
4-6	205-213	diameter	abstract|abstract[14]	new|new[14]	coref	5-11[20_0]
4-7	214-222	increase	abstract[14]	new[14]	_	_
4-8	223-225	of	abstract[14]	new[14]	_	_
4-9	226-228	at	abstract[14]|quantity[15]	new[14]|new[15]	_	_
4-10	229-234	least	abstract[14]|quantity[15]	new[14]|new[15]	_	_
4-11	235-237	50	abstract[14]|quantity[15]	new[14]|new[15]	_	_
4-12	238-239	%	abstract[14]|quantity[15]	new[14]|new[15]	_	_
4-13	240-248	compared	_	_	_	_
4-14	249-251	to	_	_	_	_
4-15	252-255	the	abstract[16]	new[16]	_	_
4-16	256-262	normal	abstract[16]	new[16]	_	_
4-17	263-270	arteria	abstract[16]	new[16]	_	_
4-18	271-272	,	_	_	_	_
4-19	273-278	which	_	_	_	_
4-20	279-287	measures	_	_	_	_
4-21	288-300	indicatively	quantity[17]	new[17]	_	_
4-22	301-302	2	quantity[17]	new[17]	_	_
4-23	303-305	cm	quantity[17]	new[17]	_	_
4-24	306-307	.	_	_	_	_

#Text=Thus , a segment of the abdominal aorta in which the diameter is equal or greater than 3.0 cm is generally considered an aortic aneurysm .
5-1	308-312	Thus	_	_	_	_
5-2	313-314	,	_	_	_	_
5-3	315-316	a	object[18]	new[18]	_	_
5-4	317-324	segment	object[18]	new[18]	_	_
5-5	325-327	of	object[18]	new[18]	_	_
5-6	328-331	the	object[18]|abstract[19]	new[18]|giv[19]	coref	5-24[0_19]
5-7	332-341	abdominal	object[18]|abstract[19]	new[18]|giv[19]	_	_
5-8	342-347	aorta	object[18]|abstract[19]	new[18]|giv[19]	_	_
5-9	348-350	in	_	_	_	_
5-10	351-356	which	_	_	_	_
5-11	357-360	the	abstract[20]	giv[20]	coref	8-45[72_20]
5-12	361-369	diameter	abstract[20]	giv[20]	_	_
5-13	370-372	is	_	_	_	_
5-14	373-378	equal	_	_	_	_
5-15	379-381	or	_	_	_	_
5-16	382-389	greater	_	_	_	_
5-17	390-394	than	_	_	_	_
5-18	395-398	3.0	quantity[21]	new[21]	_	_
5-19	399-401	cm	quantity[21]	new[21]	_	_
5-20	402-404	is	_	_	_	_
5-21	405-414	generally	_	_	_	_
5-22	415-425	considered	_	_	_	_
5-23	426-428	an	organization[23]	giv[23]	coref	6-6[0_23]
5-24	429-435	aortic	abstract|organization[23]	giv|giv[23]	coref	20-12
5-25	436-444	aneurysm	organization[23]	giv[23]	_	_
5-26	445-446	.	_	_	_	_

#Text=In developed countries , an AAA rupture represents an important cause of death with a mortality rate of approximatively 80 – 90 % ; several risk factors are associated with the development of AAA including advanced age , male sex , Caucasian race , positive family history , smoking , presence of other large vessel aneurysms , and atherosclerosis .
6-1	447-449	In	_	_	_	_
6-2	450-459	developed	place[24]	new[24]	_	_
6-3	460-469	countries	place[24]	new[24]	_	_
6-4	470-471	,	_	_	_	_
6-5	472-474	an	event[26]	new[26]	coref	8-16[0_26]
6-6	475-478	AAA	organization|event[26]	giv|new[26]	coref	6-34
6-7	479-486	rupture	event[26]	new[26]	_	_
6-8	487-497	represents	_	_	_	_
6-9	498-500	an	abstract[27]	new[27]	_	_
6-10	501-510	important	abstract[27]	new[27]	_	_
6-11	511-516	cause	abstract[27]	new[27]	_	_
6-12	517-519	of	abstract[27]	new[27]	_	_
6-13	520-525	death	abstract[27]|event	new[27]|new	_	_
6-14	526-530	with	abstract[27]	new[27]	_	_
6-15	531-532	a	abstract[27]|abstract[30]	new[27]|new[30]	_	_
6-16	533-542	mortality	abstract[27]|abstract|abstract[30]	new[27]|new|new[30]	_	_
6-17	543-547	rate	abstract[27]|abstract[30]	new[27]|new[30]	_	_
6-18	548-550	of	abstract[27]|abstract[30]	new[27]|new[30]	_	_
6-19	551-566	approximatively	abstract[27]|abstract[30]|quantity[32]	new[27]|new[30]|new[32]	_	_
6-20	567-569	80	abstract[27]|abstract[30]|quantity[32]	new[27]|new[30]|new[32]	_	_
6-21	570-571	–	abstract[27]|abstract[30]|quantity[32]	new[27]|new[30]|new[32]	_	_
6-22	572-574	90	abstract[27]|abstract[30]|quantity|quantity[32]	new[27]|new[30]|new|new[32]	_	_
6-23	575-576	%	abstract[27]|abstract[30]|quantity[32]	new[27]|new[30]|new[32]	_	_
6-24	577-578	;	_	_	_	_
6-25	579-586	several	abstract[34]	new[34]	coref	7-32[52_34]
6-26	587-591	risk	abstract|abstract[34]	new|new[34]	coref	8-30[67_0]
6-27	592-599	factors	abstract[34]	new[34]	_	_
6-28	600-603	are	_	_	_	_
6-29	604-614	associated	_	_	_	_
6-30	615-619	with	_	_	_	_
6-31	620-623	the	abstract[35]	new[35]	_	_
6-32	624-635	development	abstract[35]	new[35]	_	_
6-33	636-638	of	abstract[35]	new[35]	_	_
6-34	639-642	AAA	abstract[35]|organization	new[35]|giv	coref	7-42[55_0]
6-35	643-652	including	abstract[35]	new[35]	_	_
6-36	653-661	advanced	abstract[35]|abstract[37]	new[35]|new[37]	_	_
6-37	662-665	age	abstract[35]|abstract[37]	new[35]|new[37]	_	_
6-38	666-667	,	abstract[35]	new[35]	_	_
6-39	668-672	male	abstract[35]|abstract[38]	new[35]|new[38]	_	_
6-40	673-676	sex	abstract[35]|abstract[38]	new[35]|new[38]	_	_
6-41	677-678	,	abstract[35]	new[35]	_	_
6-42	679-688	Caucasian	abstract[35]|abstract[39]	new[35]|new[39]	_	_
6-43	689-693	race	abstract[35]|abstract[39]	new[35]|new[39]	_	_
6-44	694-695	,	abstract[35]	new[35]	_	_
6-45	696-704	positive	abstract[35]|abstract[41]	new[35]|new[41]	_	_
6-46	705-711	family	abstract[35]|abstract|abstract[41]	new[35]|new|new[41]	_	_
6-47	712-719	history	abstract[35]|abstract[41]	new[35]|new[41]	_	_
6-48	720-721	,	abstract[35]	new[35]	_	_
6-49	722-729	smoking	abstract[35]	new[35]	_	_
6-50	730-731	,	abstract[35]	new[35]	_	_
6-51	732-740	presence	abstract[35]|abstract[42]	new[35]|new[42]	_	_
6-52	741-743	of	abstract[35]|abstract[42]	new[35]|new[42]	_	_
6-53	744-749	other	abstract[35]|abstract[42]|object[44]	new[35]|new[42]|new[44]	_	_
6-54	750-755	large	abstract[35]|abstract[42]|object[44]	new[35]|new[42]|new[44]	_	_
6-55	756-762	vessel	abstract[35]|abstract[42]|object|object[44]	new[35]|new[42]|giv|new[44]	coref	18-32[191_0]
6-56	763-772	aneurysms	abstract[35]|abstract[42]|object[44]	new[35]|new[42]|new[44]	_	_
6-57	773-774	,	abstract[35]	new[35]	_	_
6-58	775-778	and	abstract[35]	new[35]	_	_
6-59	779-794	atherosclerosis	abstract[35]|abstract	new[35]|new	_	_
6-60	795-796	.	_	_	_	_

#Text=Despite the clinical importance of AAAs , the etiology and the involved pathogenesis remain still , in part , unclear ; it is , then , evident how the identification of the factors that can influence the growth and progression of the aneurysm is fundamental for Public Health management .
7-1	797-804	Despite	_	_	_	_
7-2	805-808	the	abstract[46]	new[46]	_	_
7-3	809-817	clinical	abstract[46]	new[46]	_	_
7-4	818-828	importance	abstract[46]	new[46]	_	_
7-5	829-831	of	abstract[46]	new[46]	_	_
7-6	832-836	AAAs	abstract[46]|object	new[46]|new	coref	9-14
7-7	837-838	,	_	_	_	_
7-8	839-842	the	abstract[48]	new[48]	_	_
7-9	843-851	etiology	abstract[48]	new[48]	_	_
7-10	852-855	and	_	_	_	_
7-11	856-859	the	abstract[49]	new[49]	ana	7-22[0_49]
7-12	860-868	involved	abstract[49]	new[49]	_	_
7-13	869-881	pathogenesis	abstract[49]	new[49]	_	_
7-14	882-888	remain	_	_	_	_
7-15	889-894	still	_	_	_	_
7-16	895-896	,	_	_	_	_
7-17	897-899	in	_	_	_	_
7-18	900-904	part	_	_	_	_
7-19	905-906	,	_	_	_	_
7-20	907-914	unclear	_	_	_	_
7-21	915-916	;	_	_	_	_
7-22	917-919	it	abstract	giv	_	_
7-23	920-922	is	_	_	_	_
7-24	923-924	,	_	_	_	_
7-25	925-929	then	_	_	_	_
7-26	930-931	,	_	_	_	_
7-27	932-939	evident	_	_	_	_
7-28	940-943	how	_	_	_	_
7-29	944-947	the	abstract[51]	new[51]	_	_
7-30	948-962	identification	abstract[51]	new[51]	_	_
7-31	963-965	of	abstract[51]	new[51]	_	_
7-32	966-969	the	abstract[51]|abstract[52]	new[51]|giv[52]	coref	10-28[90_52]
7-33	970-977	factors	abstract[51]|abstract[52]	new[51]|giv[52]	_	_
7-34	978-982	that	_	_	_	_
7-35	983-986	can	_	_	_	_
7-36	987-996	influence	_	_	_	_
7-37	997-1000	the	abstract[53]	new[53]	_	_
7-38	1001-1007	growth	abstract[53]	new[53]	_	_
7-39	1008-1011	and	_	_	_	_
7-40	1012-1023	progression	abstract[54]	new[54]	_	_
7-41	1024-1026	of	abstract[54]	new[54]	_	_
7-42	1027-1030	the	abstract[54]|organization[55]	new[54]|giv[55]	coref	8-7[60_55]
7-43	1031-1039	aneurysm	abstract[54]|organization[55]	new[54]|giv[55]	_	_
7-44	1040-1042	is	_	_	_	_
7-45	1043-1054	fundamental	_	_	_	_
7-46	1055-1058	for	_	_	_	_
7-47	1059-1065	Public	abstract[56]|abstract[57]	new[56]|new[57]	_	_
7-48	1066-1072	Health	abstract[56]|abstract[57]	new[56]|new[57]	_	_
7-49	1073-1083	management	abstract[57]	new[57]	_	_
7-50	1084-1085	.	_	_	_	_

#Text=For asymptomatic patients , repair of the aneurysm is the most effective treatment to prevent rupture but considering the risks associated with surgery , AAA repair is recommended if the risk of rupture exceeds the risks associated with surgery , which typically occurs when the AAA diameter exceeds 5.5 cm .
8-1	1086-1089	For	_	_	_	_
8-2	1090-1102	asymptomatic	person[58]	new[58]	_	_
8-3	1103-1111	patients	person[58]	new[58]	_	_
8-4	1112-1113	,	_	_	_	_
8-5	1114-1120	repair	abstract[59]	new[59]	coref	8-10[61_59]
8-6	1121-1123	of	abstract[59]	new[59]	_	_
8-7	1124-1127	the	abstract[59]|organization[60]	new[59]|giv[60]	coref	8-25[0_60]
8-8	1128-1136	aneurysm	abstract[59]|organization[60]	new[59]|giv[60]	_	_
8-9	1137-1139	is	_	_	_	_
8-10	1140-1143	the	abstract[61]	giv[61]	coref	8-25[66_61]
8-11	1144-1148	most	abstract[61]	giv[61]	_	_
8-12	1149-1158	effective	abstract[61]	giv[61]	_	_
8-13	1159-1168	treatment	abstract[61]	giv[61]	_	_
8-14	1169-1171	to	_	_	_	_
8-15	1172-1179	prevent	_	_	_	_
8-16	1180-1187	rupture	event	giv	coref	8-33
8-17	1188-1191	but	_	_	_	_
8-18	1192-1203	considering	_	_	_	_
8-19	1204-1207	the	quantity[63]	new[63]	coref	8-35[69_63]
8-20	1208-1213	risks	quantity[63]	new[63]	_	_
8-21	1214-1224	associated	_	_	_	_
8-22	1225-1229	with	_	_	_	_
8-23	1230-1237	surgery	event	new	coref	8-39
8-24	1238-1239	,	_	_	_	_
8-25	1240-1243	AAA	organization|abstract[66]	giv|giv[66]	coref|coref	8-46|8-46
8-26	1244-1250	repair	abstract[66]	giv[66]	_	_
8-27	1251-1253	is	_	_	_	_
8-28	1254-1265	recommended	_	_	_	_
8-29	1266-1268	if	_	_	_	_
8-30	1269-1272	the	abstract[67]	giv[67]	coref	10-29[0_67]
8-31	1273-1277	risk	abstract[67]	giv[67]	_	_
8-32	1278-1280	of	abstract[67]	giv[67]	_	_
8-33	1281-1288	rupture	abstract[67]|event	giv[67]|giv	coref	9-9
8-34	1289-1296	exceeds	_	_	_	_
8-35	1297-1300	the	abstract[69]	giv[69]	_	_
8-36	1301-1306	risks	abstract[69]	giv[69]	_	_
8-37	1307-1317	associated	_	_	_	_
8-38	1318-1322	with	_	_	_	_
8-39	1323-1330	surgery	event	giv	_	_
8-40	1331-1332	,	_	_	_	_
8-41	1333-1338	which	_	_	_	_
8-42	1339-1348	typically	_	_	_	_
8-43	1349-1355	occurs	_	_	_	_
8-44	1356-1360	when	_	_	_	_
8-45	1361-1364	the	abstract[72]	giv[72]	coref	9-2[75_72]
8-46	1365-1368	AAA	organization|abstract[72]	giv|giv[72]	coref	9-2
8-47	1369-1377	diameter	abstract[72]	giv[72]	_	_
8-48	1378-1385	exceeds	_	_	_	_
8-49	1386-1389	5.5	quantity[73]	new[73]	_	_
8-50	1390-1392	cm	quantity[73]	new[73]	_	_
8-51	1393-1394	.	_	_	_	_

#Text=Although AAA diameter is an important predictor of rupture , not all large AAAs break , it is then fundamental to look at this phenomenon in a more complex framework .
9-1	1395-1403	Although	_	_	_	_
9-2	1404-1407	AAA	organization|abstract[75]	giv|giv[75]	coref|coref|coref|coref	9-5[76_75]|12-27|9-5[76_75]|12-27
9-3	1408-1416	diameter	abstract[75]	giv[75]	_	_
9-4	1417-1419	is	_	_	_	_
9-5	1420-1422	an	abstract[76]	giv[76]	coref	12-25[117_76]
9-6	1423-1432	important	abstract[76]	giv[76]	_	_
9-7	1433-1442	predictor	abstract[76]	giv[76]	_	_
9-8	1443-1445	of	abstract[76]	giv[76]	_	_
9-9	1446-1453	rupture	abstract[76]|event	giv[76]|giv	coref	12-11
9-10	1454-1455	,	abstract[76]	giv[76]	_	_
9-11	1456-1459	not	abstract[76]	giv[76]	_	_
9-12	1460-1463	all	abstract[76]|event[79]	giv[76]|new[79]	_	_
9-13	1464-1469	large	abstract[76]|event[79]	giv[76]|new[79]	_	_
9-14	1470-1474	AAAs	abstract[76]|abstract|event[79]	giv[76]|giv|new[79]	coref	10-23
9-15	1475-1480	break	abstract[76]|event[79]	giv[76]|new[79]	_	_
9-16	1481-1482	,	_	_	_	_
9-17	1483-1485	it	abstract	new	cata	9-17[0_81]
9-18	1486-1488	is	_	_	_	_
9-19	1489-1493	then	_	_	_	_
9-20	1494-1505	fundamental	_	_	_	_
9-21	1506-1508	to	abstract[81]	new[81]	_	_
9-22	1509-1513	look	abstract[81]	new[81]	_	_
9-23	1514-1516	at	_	_	_	_
9-24	1517-1521	this	abstract[82]	new[82]	_	_
9-25	1522-1532	phenomenon	abstract[82]	new[82]	_	_
9-26	1533-1535	in	_	_	_	_
9-27	1536-1537	a	abstract[83]	new[83]	_	_
9-28	1538-1542	more	abstract[83]	new[83]	_	_
9-29	1543-1550	complex	abstract[83]	new[83]	_	_
9-30	1551-1560	framework	abstract[83]	new[83]	_	_
9-31	1561-1562	.	_	_	_	_

#Text=To this aim , clinical , experimental , and numerical studies are being widely performed , focusing on the deep investigation of AAAs and the determination of possible risk factors , as well as on reproducing their hemodynamics .
10-1	1563-1565	To	_	_	_	_
10-2	1566-1570	this	abstract[84]	new[84]	coref	23-19[237_84]
10-3	1571-1574	aim	abstract[84]	new[84]	_	_
10-4	1575-1576	,	_	_	_	_
10-5	1577-1585	clinical	abstract[85]	new[85]	_	_
10-6	1586-1587	,	abstract[85]	new[85]	_	_
10-7	1588-1600	experimental	abstract[85]	new[85]	_	_
10-8	1601-1602	,	abstract[85]	new[85]	_	_
10-9	1603-1606	and	abstract[85]	new[85]	_	_
10-10	1607-1616	numerical	abstract[85]	new[85]	_	_
10-11	1617-1624	studies	abstract[85]	new[85]	_	_
10-12	1625-1628	are	_	_	_	_
10-13	1629-1634	being	_	_	_	_
10-14	1635-1641	widely	_	_	_	_
10-15	1642-1651	performed	_	_	_	_
10-16	1652-1653	,	_	_	_	_
10-17	1654-1662	focusing	_	_	_	_
10-18	1663-1665	on	_	_	_	_
10-19	1666-1669	the	abstract[86]	new[86]	_	_
10-20	1670-1674	deep	abstract[86]	new[86]	_	_
10-21	1675-1688	investigation	abstract[86]	new[86]	_	_
10-22	1689-1691	of	abstract[86]	new[86]	_	_
10-23	1692-1696	AAAs	abstract[86]|object	new[86]|giv	coref	21-11[214_0]
10-24	1697-1700	and	_	_	_	_
10-25	1701-1704	the	abstract[88]	new[88]	_	_
10-26	1705-1718	determination	abstract[88]	new[88]	_	_
10-27	1719-1721	of	abstract[88]	new[88]	_	_
10-28	1722-1730	possible	abstract[88]|abstract[90]	new[88]|giv[90]	ana	10-37[0_90]
10-29	1731-1735	risk	abstract[88]|abstract|abstract[90]	new[88]|giv|giv[90]	coref	12-8[112_0]
10-30	1736-1743	factors	abstract[88]|abstract[90]	new[88]|giv[90]	_	_
10-31	1744-1745	,	_	_	_	_
10-32	1746-1748	as	_	_	_	_
10-33	1749-1753	well	_	_	_	_
10-34	1754-1756	as	_	_	_	_
10-35	1757-1759	on	_	_	_	_
10-36	1760-1771	reproducing	_	_	_	_
10-37	1772-1777	their	abstract|abstract[92]	giv|new[92]	coref|coref|coref|coref	11-3[93_92]|22-26[231_0]|11-3[93_92]|22-26[231_0]
10-38	1778-1790	hemodynamics	abstract[92]	new[92]	_	_
10-39	1791-1792	.	_	_	_	_

#Text=Usually , the local hemodynamics is quantified in terms of the distributions of wall pressure , wall shear stress ( WSS ) , and wall shear stress gradient ( WSSG ) .
11-1	1793-1800	Usually	_	_	_	_
11-2	1801-1802	,	_	_	_	_
11-3	1803-1806	the	abstract[93]	giv[93]	coref	27-15[0_93]
11-4	1807-1812	local	abstract[93]	giv[93]	_	_
11-5	1813-1825	hemodynamics	abstract[93]	giv[93]	_	_
11-6	1826-1828	is	_	_	_	_
11-7	1829-1839	quantified	_	_	_	_
11-8	1840-1842	in	_	_	_	_
11-9	1843-1848	terms	_	_	_	_
11-10	1849-1851	of	_	_	_	_
11-11	1852-1855	the	abstract[94]	new[94]	_	_
11-12	1856-1869	distributions	abstract[94]	new[94]	_	_
11-13	1870-1872	of	abstract[94]	new[94]	_	_
11-14	1873-1877	wall	abstract[94]|object|abstract[96]	new[94]|giv|new[96]	coref|coref|coref|coref	11-17|15-52[142_96]|11-17|15-52[142_96]
11-15	1878-1886	pressure	abstract[94]|abstract[96]	new[94]|new[96]	_	_
11-16	1887-1888	,	abstract[94]	new[94]	_	_
11-17	1889-1893	wall	abstract[94]|object|abstract[99]	new[94]|giv|new[99]	appos|coref|appos|coref	11-21[0_99]|11-25|11-21[0_99]|11-25
11-18	1894-1899	shear	abstract[94]|place|abstract[99]	new[94]|new|new[99]	coref	11-26
11-19	1900-1906	stress	abstract[94]|abstract[99]	new[94]|new[99]	_	_
11-20	1907-1908	(	abstract[94]	new[94]	_	_
11-21	1909-1912	WSS	abstract[94]|abstract	new[94]|giv	coref	11-27
11-22	1913-1914	)	abstract[94]	new[94]	_	_
11-23	1915-1916	,	abstract[94]	new[94]	_	_
11-24	1917-1920	and	abstract[94]	new[94]	_	_
11-25	1921-1925	wall	abstract[94]|object|abstract[104]	new[94]|giv|new[104]	appos|coref|appos|coref	11-30[0_104]|12-10|11-30[0_104]|12-10
11-26	1926-1931	shear	abstract[94]|abstract|abstract[104]	new[94]|giv|new[104]	coref	15-56
11-27	1932-1938	stress	abstract[94]|abstract|abstract[104]	new[94]|giv|new[104]	coref	12-1[107_0]
11-28	1939-1947	gradient	abstract[94]|abstract[104]	new[94]|new[104]	_	_
11-29	1948-1949	(	_	_	_	_
11-30	1950-1954	WSSG	abstract	giv	coref	15-62[150_0]
11-31	1955-1956	)	_	_	_	_
11-32	1957-1958	.	_	_	_	_

#Text=The peak WSS ( PWSS ) and the peak wall rupture risk ( PWRR ) have proved to be better predictors of rupture than the maximum AAA diameter ( [ 7 ] and reference therein , ) .
12-1	1959-1962	The	abstract[107]	giv[107]	appos	12-5[0_107]
12-2	1963-1967	peak	abstract|abstract[107]	new|giv[107]	coref	12-9
12-3	1968-1971	WSS	abstract[107]	giv[107]	_	_
12-4	1972-1973	(	_	_	_	_
12-5	1974-1978	PWSS	abstract	giv	coref	15-55[145_0]
12-6	1979-1980	)	_	_	_	_
12-7	1981-1984	and	_	_	_	_
12-8	1985-1988	the	abstract[112]	giv[112]	appos	12-14[0_112]
12-9	1989-1993	peak	abstract|abstract[112]	giv|giv[112]	_	_
12-10	1994-1998	wall	object|abstract[112]	giv|giv[112]	coref	15-52
12-11	1999-2006	rupture	event|abstract[112]	giv|giv[112]	coref	12-23[115_0]
12-12	2007-2011	risk	abstract[112]	giv[112]	_	_
12-13	2012-2013	(	_	_	_	_
12-14	2014-2018	PWRR	abstract	giv	coref	18-16[187_0]
12-15	2019-2020	)	_	_	_	_
12-16	2021-2025	have	_	_	_	_
12-17	2026-2032	proved	_	_	_	_
12-18	2033-2035	to	_	_	_	_
12-19	2036-2038	be	_	_	_	_
12-20	2039-2045	better	abstract[114]	new[114]	_	_
12-21	2046-2056	predictors	abstract[114]	new[114]	_	_
12-22	2057-2059	of	abstract[114]	new[114]	_	_
12-23	2060-2067	rupture	abstract[114]|event[115]	new[114]|giv[115]	coref	18-18[0_115]
12-24	2068-2072	than	abstract[114]|event[115]	new[114]|giv[115]	_	_
12-25	2073-2076	the	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-26	2077-2084	maximum	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-27	2085-2088	AAA	abstract[114]|event[115]|organization|abstract[117]	new[114]|giv[115]|giv|giv[117]	coref	13-7[123_0]
12-28	2089-2097	diameter	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-29	2098-2099	(	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-30	2100-2101	[	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-31	2102-2103	7	abstract[114]|event[115]|abstract[117]|abstract	new[114]|giv[115]|giv[117]|new	_	_
12-32	2104-2105	]	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-33	2106-2109	and	abstract[114]|event[115]|abstract[117]	new[114]|giv[115]|giv[117]	_	_
12-34	2110-2119	reference	abstract[114]|event[115]|abstract[117]|abstract[119]	new[114]|giv[115]|giv[117]|new[119]	_	_
12-35	2120-2127	therein	abstract[114]|event[115]|abstract[117]|abstract[119]	new[114]|giv[115]|giv[117]|new[119]	_	_
12-36	2128-2129	,	_	_	_	_
12-37	2130-2131	)	_	_	_	_
12-38	2132-2133	.	_	_	_	_

#Text=The blood flow patterns associated with an AAA have been widely investigated via numerical methods .
13-1	2134-2137	The	abstract[122]	new[122]	_	_
13-2	2138-2143	blood	substance|abstract[122]	new|new[122]	coref	15-19[133_0]
13-3	2144-2148	flow	abstract|abstract[122]	new|new[122]	coref	15-7
13-4	2149-2157	patterns	abstract[122]	new[122]	_	_
13-5	2158-2168	associated	_	_	_	_
13-6	2169-2173	with	_	_	_	_
13-7	2174-2176	an	organization[123]	giv[123]	coref	16-33[160_123]
13-8	2177-2180	AAA	organization[123]	giv[123]	_	_
13-9	2181-2185	have	_	_	_	_
13-10	2186-2190	been	_	_	_	_
13-11	2191-2197	widely	_	_	_	_
13-12	2198-2210	investigated	_	_	_	_
13-13	2211-2214	via	_	_	_	_
13-14	2215-2224	numerical	abstract[124]	new[124]	_	_
13-15	2225-2232	methods	abstract[124]	new[124]	_	_
13-16	2233-2234	.	_	_	_	_

#Text=The models may consider different levels of complexity .
14-1	2235-2238	The	abstract[125]	new[125]	coref	23-37[242_125]
14-2	2239-2245	models	abstract[125]	new[125]	_	_
14-3	2246-2249	may	_	_	_	_
14-4	2250-2258	consider	_	_	_	_
14-5	2259-2268	different	abstract[126]	new[126]	_	_
14-6	2269-2275	levels	abstract[126]	new[126]	_	_
14-7	2276-2278	of	abstract[126]	new[126]	_	_
14-8	2279-2289	complexity	abstract[126]|abstract	new[126]|new	coref	23-34
14-9	2290-2291	.	_	_	_	_

#Text=In , the authors investigated the flow field in an axisymmetric two-aneurysm model with rigid walls and assuming the blood as a Newtonian incompressible fluid in stationary conditions and in a range of Reynolds numbers 10 < Re < 2265 ; the flow was characterized in terms of the distributions of wall pressure , wall shear stress ( WSS ) and wall shear stress gradient ( WSSG ) .
15-1	2292-2294	In	_	_	_	_
15-2	2295-2296	,	_	_	_	_
15-3	2297-2300	the	person[128]	new[128]	coref	19-3[195_128]
15-4	2301-2308	authors	person[128]	new[128]	_	_
15-5	2309-2321	investigated	_	_	_	_
15-6	2322-2325	the	abstract[130]	new[130]	coref	27-5[0_130]
15-7	2326-2330	flow	abstract|abstract[130]	giv|new[130]	coref	15-42[139_0]
15-8	2331-2336	field	abstract[130]	new[130]	_	_
15-9	2337-2339	in	abstract[130]	new[130]	_	_
15-10	2340-2342	an	abstract[130]|abstract[131]	new[130]|new[131]	coref	24-20[251_131]
15-11	2343-2355	axisymmetric	abstract[130]|abstract[131]	new[130]|new[131]	_	_
15-12	2356-2368	two-aneurysm	abstract[130]|abstract[131]	new[130]|new[131]	_	_
15-13	2369-2374	model	abstract[130]|abstract[131]	new[130]|new[131]	_	_
15-14	2375-2379	with	abstract[130]|abstract[131]	new[130]|new[131]	_	_
15-15	2380-2385	rigid	abstract[130]|abstract[131]|object[132]	new[130]|new[131]|new[132]	coref	16-37[161_132]
15-16	2386-2391	walls	abstract[130]|abstract[131]|object[132]	new[130]|new[131]|new[132]	_	_
15-17	2392-2395	and	_	_	_	_
15-18	2396-2404	assuming	_	_	_	_
15-19	2405-2408	the	substance[133]	giv[133]	coref	22-19[0_133]
15-20	2409-2414	blood	substance[133]	giv[133]	_	_
15-21	2415-2417	as	substance[133]	giv[133]	_	_
15-22	2418-2419	a	substance[133]	giv[133]	_	_
15-23	2420-2429	Newtonian	substance[133]|person	giv[133]|new	_	_
15-24	2430-2444	incompressible	substance[133]	giv[133]	_	_
15-25	2445-2450	fluid	substance[133]	giv[133]	_	_
15-26	2451-2453	in	substance[133]	giv[133]	_	_
15-27	2454-2464	stationary	substance[133]|abstract[135]	giv[133]|new[135]	coref	16-54[166_135]
15-28	2465-2475	conditions	substance[133]|abstract[135]	giv[133]|new[135]	_	_
15-29	2476-2479	and	_	_	_	_
15-30	2480-2482	in	_	_	_	_
15-31	2483-2484	a	_	_	_	_
15-32	2485-2490	range	_	_	_	_
15-33	2491-2493	of	_	_	_	_
15-34	2494-2502	Reynolds	person|abstract[137]	new|new[137]	_	_
15-35	2503-2510	numbers	abstract[137]	new[137]	_	_
15-36	2511-2513	10	abstract[137]	new[137]	_	_
15-37	2514-2515	<	_	_	_	_
15-38	2516-2518	Re	abstract	new	coref	16-46
15-39	2519-2520	<	_	_	_	_
15-40	2521-2525	2265	_	_	_	_
15-41	2526-2527	;	_	_	_	_
15-42	2528-2531	the	abstract[139]	giv[139]	coref	16-26[156_139]
15-43	2532-2536	flow	abstract[139]	giv[139]	_	_
15-44	2537-2540	was	_	_	_	_
15-45	2541-2554	characterized	_	_	_	_
15-46	2555-2557	in	_	_	_	_
15-47	2558-2563	terms	_	_	_	_
15-48	2564-2566	of	_	_	_	_
15-49	2567-2570	the	abstract[140]	new[140]	coref	25-10[260_140]
15-50	2571-2584	distributions	abstract[140]	new[140]	_	_
15-51	2585-2587	of	abstract[140]	new[140]	_	_
15-52	2588-2592	wall	abstract[140]|object|abstract[142]	new[140]|giv|giv[142]	coref|coref	15-55|15-55
15-53	2593-2601	pressure	abstract[140]|abstract[142]	new[140]|giv[142]	_	_
15-54	2602-2603	,	abstract[140]	new[140]	_	_
15-55	2604-2608	wall	abstract[140]|object|abstract[145]	new[140]|giv|giv[145]	coref|coref|coref|coref	15-59[0_145]|15-62|15-59[0_145]|15-62
15-56	2609-2614	shear	abstract[140]|place|abstract[145]	new[140]|giv|giv[145]	coref	15-63
15-57	2615-2621	stress	abstract[140]|abstract[145]	new[140]|giv[145]	_	_
15-58	2622-2623	(	abstract[140]	new[140]	_	_
15-59	2624-2627	WSS	abstract[140]|abstract	new[140]|giv	coref	15-64
15-60	2628-2629	)	abstract[140]	new[140]	_	_
15-61	2630-2633	and	abstract[140]	new[140]	_	_
15-62	2634-2638	wall	abstract[140]|object|abstract[150]	new[140]|giv|giv[150]	coref|coref|coref|coref	15-67[0_150]|18-31[192_0]|15-67[0_150]|18-31[192_0]
15-63	2639-2644	shear	abstract[140]|abstract|abstract[150]	new[140]|giv|giv[150]	_	_
15-64	2645-2651	stress	abstract[140]|abstract|abstract[150]	new[140]|giv|giv[150]	coref	19-23[204_0]
15-65	2652-2660	gradient	abstract[140]|abstract[150]	new[140]|giv[150]	_	_
15-66	2661-2662	(	_	_	_	_
15-67	2663-2667	WSSG	abstract	giv	coref	25-10
15-68	2668-2669	)	_	_	_	_
15-69	2670-2671	.	_	_	_	_

#Text=In the role of the shape and of the geometric features , as asymmetry and iliac bifurcation , are investigated ; in the correlation between blood flow and platelet deposition mechanisms in an axisymmetric aneurysm with rigid walls was investigated in the range 300 < Re < 3600 , i. e. , under both laminar and turbulent flow conditions .
16-1	2672-2674	In	_	_	_	_
16-2	2675-2678	the	abstract[152]	new[152]	_	_
16-3	2679-2683	role	abstract[152]	new[152]	_	_
16-4	2684-2686	of	abstract[152]	new[152]	_	_
16-5	2687-2690	the	abstract[152]|abstract[153]	new[152]|new[153]	_	_
16-6	2691-2696	shape	abstract[152]|abstract[153]	new[152]|new[153]	_	_
16-7	2697-2700	and	_	_	_	_
16-8	2701-2703	of	_	_	_	_
16-9	2704-2707	the	_	_	_	_
16-10	2708-2717	geometric	_	_	_	_
16-11	2718-2726	features	_	_	_	_
16-12	2727-2728	,	_	_	_	_
16-13	2729-2731	as	_	_	_	_
16-14	2732-2741	asymmetry	_	_	_	_
16-15	2742-2745	and	_	_	_	_
16-16	2746-2751	iliac	person	new	_	_
16-17	2752-2763	bifurcation	_	_	_	_
16-18	2764-2765	,	_	_	_	_
16-19	2766-2769	are	_	_	_	_
16-20	2770-2782	investigated	_	_	_	_
16-21	2783-2784	;	_	_	_	_
16-22	2785-2787	in	_	_	_	_
16-23	2788-2791	the	abstract[155]	new[155]	_	_
16-24	2792-2803	correlation	abstract[155]	new[155]	_	_
16-25	2804-2811	between	abstract[155]	new[155]	_	_
16-26	2812-2817	blood	abstract[155]|abstract[156]	new[155]|giv[156]	coref	16-58[0_156]
16-27	2818-2822	flow	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
16-28	2823-2826	and	abstract[155]	new[155]	_	_
16-29	2827-2835	platelet	abstract[155]|substance|abstract[159]	new[155]|new|new[159]	coref|coref	17-35|17-35
16-30	2836-2846	deposition	abstract[155]|abstract|abstract[159]	new[155]|new|new[159]	coref	17-36
16-31	2847-2857	mechanisms	abstract[155]|abstract[159]	new[155]|new[159]	_	_
16-32	2858-2860	in	abstract[155]|abstract[159]	new[155]|new[159]	_	_
16-33	2861-2863	an	abstract[155]|abstract[159]|organization[160]	new[155]|new[159]|giv[160]	coref	18-38[194_160]
16-34	2864-2876	axisymmetric	abstract[155]|abstract[159]|organization[160]	new[155]|new[159]|giv[160]	_	_
16-35	2877-2885	aneurysm	abstract[155]|abstract[159]|organization[160]	new[155]|new[159]|giv[160]	_	_
16-36	2886-2890	with	abstract[155]|abstract[159]|organization[160]	new[155]|new[159]|giv[160]	_	_
16-37	2891-2896	rigid	abstract[155]|abstract[159]|organization[160]|object[161]	new[155]|new[159]|giv[160]|giv[161]	_	_
16-38	2897-2902	walls	abstract[155]|abstract[159]|organization[160]|object[161]	new[155]|new[159]|giv[160]|giv[161]	_	_
16-39	2903-2906	was	_	_	_	_
16-40	2907-2919	investigated	_	_	_	_
16-41	2920-2922	in	_	_	_	_
16-42	2923-2926	the	abstract[162]	new[162]	coref	25-48[270_162]
16-43	2927-2932	range	abstract[162]	new[162]	_	_
16-44	2933-2936	300	_	_	_	_
16-45	2937-2938	<	_	_	_	_
16-46	2939-2941	Re	person	giv	coref	25-52
16-47	2942-2943	<	_	_	_	_
16-48	2944-2948	3600	quantity	new	_	_
16-49	2949-2950	,	_	_	_	_
16-50	2951-2953	i.	_	_	_	_
16-51	2954-2956	e.	_	_	_	_
16-52	2957-2958	,	_	_	_	_
16-53	2959-2964	under	_	_	_	_
16-54	2965-2969	both	abstract[166]	giv[166]	coref	24-29[254_166]
16-55	2970-2977	laminar	abstract[166]	giv[166]	_	_
16-56	2978-2981	and	abstract[166]	giv[166]	_	_
16-57	2982-2991	turbulent	abstract[166]	giv[166]	_	_
16-58	2992-2996	flow	abstract|abstract[166]	giv|giv[166]	coref	17-25
16-59	2997-3007	conditions	abstract[166]	giv[166]	_	_
16-60	3008-3009	.	_	_	_	_

#Text=The numerical simulations performed using a computational fluid dynamics ( CFD ) package , were validated through digital particle image velocimetry ( PIV ) flow measurements that allowed correlating the flow pattern with the platelet deposition mechanism .
17-1	3010-3013	The	abstract[167]	new[167]	_	_
17-2	3014-3023	numerical	abstract[167]	new[167]	_	_
17-3	3024-3035	simulations	abstract[167]	new[167]	_	_
17-4	3036-3045	performed	_	_	_	_
17-5	3046-3051	using	_	_	_	_
17-6	3052-3053	a	abstract[169]	new[169]	appos	17-11[0_169]
17-7	3054-3067	computational	abstract[169]	new[169]	_	_
17-8	3068-3073	fluid	substance|abstract[169]	new|new[169]	coref	25-38
17-9	3074-3082	dynamics	abstract[169]	new[169]	_	_
17-10	3083-3084	(	_	_	_	_
17-11	3085-3088	CFD	abstract	giv	coref	25-36[267_0]
17-12	3089-3090	)	_	_	_	_
17-13	3091-3098	package	object	new	_	_
17-14	3099-3100	,	_	_	_	_
17-15	3101-3105	were	_	_	_	_
17-16	3106-3115	validated	_	_	_	_
17-17	3116-3123	through	_	_	_	_
17-18	3124-3131	digital	object[173]	new[173]	coref	24-12[248_173]
17-19	3132-3140	particle	object|object[173]	new|new[173]	coref	24-13
17-20	3141-3146	image	object[173]	new[173]	_	_
17-21	3147-3158	velocimetry	object	new	appos	17-23
17-22	3159-3160	(	_	_	_	_
17-23	3161-3164	PIV	object	giv	coref	24-12[249_0]
17-24	3165-3166	)	_	_	_	_
17-25	3167-3171	flow	abstract|abstract[177]	giv|new[177]	coref|coref|coref|coref	17-31|24-9[246_177]|17-31|24-9[246_177]
17-26	3172-3184	measurements	abstract[177]	new[177]	_	_
17-27	3185-3189	that	_	_	_	_
17-28	3190-3197	allowed	_	_	_	_
17-29	3198-3209	correlating	_	_	_	_
17-30	3210-3213	the	abstract[179]	new[179]	coref	25-3[257_179]
17-31	3214-3218	flow	abstract|abstract[179]	giv|new[179]	coref	22-18[229_0]
17-32	3219-3226	pattern	abstract[179]	new[179]	_	_
17-33	3227-3231	with	_	_	_	_
17-34	3232-3235	the	abstract[182]	new[182]	_	_
17-35	3236-3244	platelet	object|abstract[182]	giv|new[182]	_	_
17-36	3245-3255	deposition	abstract|abstract[182]	giv|new[182]	_	_
17-37	3256-3265	mechanism	abstract[182]	new[182]	_	_
17-38	3266-3267	.	_	_	_	_

#Text=As a matter of fact , intra-luminal thrombus ( ILT ) has been associated with an increased rupture risk as it impacts both the biochemical and the mechanical properties of the vessel ’s wall in correspondence of the aneurysm .
18-1	3268-3270	As	_	_	_	_
18-2	3271-3272	a	_	_	_	_
18-3	3273-3279	matter	_	_	_	_
18-4	3280-3282	of	_	_	_	_
18-5	3283-3287	fact	abstract	new	_	_
18-6	3288-3289	,	_	_	_	_
18-7	3290-3303	intra-luminal	abstract[184]	new[184]	appos	18-10[0_184]
18-8	3304-3312	thrombus	abstract[184]	new[184]	_	_
18-9	3313-3314	(	_	_	_	_
18-10	3315-3318	ILT	abstract	giv	coref	19-9
18-11	3319-3320	)	_	_	_	_
18-12	3321-3324	has	_	_	_	_
18-13	3325-3329	been	_	_	_	_
18-14	3330-3340	associated	_	_	_	_
18-15	3341-3345	with	_	_	_	_
18-16	3346-3348	an	abstract[187]	giv[187]	ana	18-21[0_187]
18-17	3349-3358	increased	abstract[187]	giv[187]	_	_
18-18	3359-3366	rupture	event|abstract[187]	giv|giv[187]	coref	19-17[201_0]
18-19	3367-3371	risk	abstract[187]	giv[187]	_	_
18-20	3372-3374	as	_	_	_	_
18-21	3375-3377	it	abstract	giv	_	_
18-22	3378-3385	impacts	_	_	_	_
18-23	3386-3390	both	abstract[189]	new[189]	_	_
18-24	3391-3394	the	abstract[189]	new[189]	_	_
18-25	3395-3406	biochemical	abstract[189]	new[189]	_	_
18-26	3407-3410	and	_	_	_	_
18-27	3411-3414	the	abstract[190]	new[190]	_	_
18-28	3415-3425	mechanical	abstract[190]	new[190]	_	_
18-29	3426-3436	properties	abstract[190]	new[190]	_	_
18-30	3437-3439	of	abstract[190]	new[190]	_	_
18-31	3440-3443	the	abstract[190]|object[192]	new[190]|giv[192]	coref	19-24[0_192]
18-32	3444-3450	vessel	abstract[190]|object[191]|object[192]	new[190]|giv[191]|giv[192]	_	_
18-33	3451-3453	’s	abstract[190]|object[191]|object[192]	new[190]|giv[191]|giv[192]	_	_
18-34	3454-3458	wall	abstract[190]|object[192]	new[190]|giv[192]	_	_
18-35	3459-3461	in	abstract[190]|object[192]	new[190]|giv[192]	_	_
18-36	3462-3476	correspondence	abstract[190]|object[192]|abstract[193]	new[190]|giv[192]|new[193]	_	_
18-37	3477-3479	of	abstract[190]|object[192]|abstract[193]	new[190]|giv[192]|new[193]	_	_
18-38	3480-3483	the	abstract[190]|object[192]|abstract[193]|organization[194]	new[190]|giv[192]|new[193]|giv[194]	coref	19-17[0_194]
18-39	3484-3492	aneurysm	abstract[190]|object[192]|abstract[193]|organization[194]	new[190]|giv[192]|new[193]|giv[194]	_	_
18-40	3493-3494	.	_	_	_	_

#Text=In , the authors found that both increased ILT thickness and percentage volume are associated with AAA rupture of small aneurysms with low wall stress .
19-1	3495-3497	In	_	_	_	_
19-2	3498-3499	,	_	_	_	_
19-3	3500-3503	the	person[195]	giv[195]	ana	21-20[0_195]
19-4	3504-3511	authors	person[195]	giv[195]	_	_
19-5	3512-3517	found	_	_	_	_
19-6	3518-3522	that	_	_	_	_
19-7	3523-3527	both	abstract[197]	new[197]	_	_
19-8	3528-3537	increased	abstract[197]	new[197]	_	_
19-9	3538-3541	ILT	quantity|abstract[197]	giv|new[197]	coref	20-5
19-10	3542-3551	thickness	abstract[197]	new[197]	_	_
19-11	3552-3555	and	_	_	_	_
19-12	3556-3566	percentage	abstract|quantity[199]	new|new[199]	_	_
19-13	3567-3573	volume	quantity[199]	new[199]	_	_
19-14	3574-3577	are	_	_	_	_
19-15	3578-3588	associated	_	_	_	_
19-16	3589-3593	with	_	_	_	_
19-17	3594-3597	AAA	organization|event[201]	giv|giv[201]	coref|coref|coref|coref	21-28|21-27[217_201]|21-28|21-27[217_201]
19-18	3598-3605	rupture	event[201]	giv[201]	_	_
19-19	3606-3608	of	event[201]	giv[201]	_	_
19-20	3609-3614	small	event[201]|object[202]	giv[201]|new[202]	coref	20-18[212_202]
19-21	3615-3624	aneurysms	event[201]|object[202]	giv[201]|new[202]	_	_
19-22	3625-3629	with	event[201]|object[202]	giv[201]|new[202]	_	_
19-23	3630-3633	low	event[201]|object[202]|abstract[204]	giv[201]|new[202]|giv[204]	coref	25-7[258_204]
19-24	3634-3638	wall	event[201]|object[202]|object|abstract[204]	giv[201]|new[202]|giv|giv[204]	coref	20-13
19-25	3639-3645	stress	event[201]|object[202]|abstract[204]	giv[201]|new[202]|giv[204]	_	_
19-26	3646-3647	.	_	_	_	_

#Text=In this sense , ILT may represent a surrogate marker of aortic wall degeneration and help in discerning high-risk aneurysms .
20-1	3648-3650	In	_	_	_	_
20-2	3651-3655	this	abstract[205]	new[205]	_	_
20-3	3656-3661	sense	abstract[205]	new[205]	_	_
20-4	3662-3663	,	_	_	_	_
20-5	3664-3667	ILT	abstract	giv	_	_
20-6	3668-3671	may	_	_	_	_
20-7	3672-3681	represent	_	_	_	_
20-8	3682-3683	a	abstract[208]	new[208]	_	_
20-9	3684-3693	surrogate	abstract|abstract[208]	new|new[208]	_	_
20-10	3694-3700	marker	abstract[208]	new[208]	_	_
20-11	3701-3703	of	abstract[208]	new[208]	_	_
20-12	3704-3710	aortic	abstract[208]|abstract|abstract[211]	new[208]|giv|new[211]	coref|coref	21-43|21-43
20-13	3711-3715	wall	abstract[208]|object|abstract[211]	new[208]|giv|new[211]	coref	21-36
20-14	3716-3728	degeneration	abstract[208]|abstract[211]	new[208]|new[211]	_	_
20-15	3729-3732	and	_	_	_	_
20-16	3733-3737	help	_	_	_	_
20-17	3738-3740	in	_	_	_	_
20-18	3741-3751	discerning	object[212]	giv[212]	_	_
20-19	3752-3761	high-risk	object[212]	giv[212]	_	_
20-20	3762-3771	aneurysms	object[212]	giv[212]	_	_
20-21	3772-3773	.	_	_	_	_

#Text=By analyzing a large set of ‘ small ’ , ‘ large ’ ruptured , and non-ruptured AAAs , they were also able to show that early AAA rupture is not a result of elevated wall stresses but the result of compromised aortic wall strength .
21-1	3774-3776	By	_	_	_	_
21-2	3777-3786	analyzing	_	_	_	_
21-3	3787-3788	a	abstract[213]	new[213]	_	_
21-4	3789-3794	large	abstract[213]	new[213]	_	_
21-5	3795-3798	set	abstract[213]	new[213]	_	_
21-6	3799-3801	of	abstract[213]	new[213]	_	_
21-7	3802-3803	‘	abstract[213]	new[213]	_	_
21-8	3804-3809	small	abstract[213]	new[213]	_	_
21-9	3810-3811	’	abstract[213]	new[213]	_	_
21-10	3812-3813	,	abstract[213]	new[213]	_	_
21-11	3814-3815	‘	abstract[213]|object[214]	new[213]|giv[214]	coref	22-22[230_214]
21-12	3816-3821	large	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-13	3822-3823	’	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-14	3824-3832	ruptured	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-15	3833-3834	,	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-16	3835-3838	and	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-17	3839-3851	non-ruptured	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-18	3852-3856	AAAs	abstract[213]|object[214]	new[213]|giv[214]	_	_
21-19	3857-3858	,	_	_	_	_
21-20	3859-3863	they	person	giv	coref	22-14[227_0]
21-21	3864-3868	were	_	_	_	_
21-22	3869-3873	also	_	_	_	_
21-23	3874-3878	able	_	_	_	_
21-24	3879-3881	to	_	_	_	_
21-25	3882-3886	show	_	_	_	_
21-26	3887-3891	that	_	_	_	_
21-27	3892-3897	early	event[217]	giv[217]	coref	22-30[0_217]
21-28	3898-3901	AAA	organization|event[217]	giv|giv[217]	coref	24-26[252_0]
21-29	3902-3909	rupture	event[217]	giv[217]	_	_
21-30	3910-3912	is	_	_	_	_
21-31	3913-3916	not	_	_	_	_
21-32	3917-3918	a	_	_	_	_
21-33	3919-3925	result	_	_	_	_
21-34	3926-3928	of	_	_	_	_
21-35	3929-3937	elevated	abstract[219]	new[219]	_	_
21-36	3938-3942	wall	object|abstract[219]	giv|new[219]	coref	21-44
21-37	3943-3951	stresses	abstract[219]	new[219]	_	_
21-38	3952-3955	but	_	_	_	_
21-39	3956-3959	the	abstract[220]	new[220]	_	_
21-40	3960-3966	result	abstract[220]	new[220]	_	_
21-41	3967-3969	of	abstract[220]	new[220]	_	_
21-42	3970-3981	compromised	abstract[220]|abstract[223]	new[220]|new[223]	_	_
21-43	3982-3988	aortic	abstract[220]|abstract|abstract[223]	new[220]|giv|new[223]	_	_
21-44	3989-3993	wall	abstract[220]|object|abstract[223]	new[220]|giv|new[223]	_	_
21-45	3994-4002	strength	abstract[220]|abstract[223]	new[220]|new[223]	_	_
21-46	4003-4004	.	_	_	_	_

#Text=Similar findings were obtained by Boyd et al. ; in this case , the authors numerically simulated the blood flow in ruptured AAAs to correlate local hemodynamic factors with rupture location .
22-1	4005-4012	Similar	abstract[224]	new[224]	_	_
22-2	4013-4021	findings	abstract[224]	new[224]	_	_
22-3	4022-4026	were	_	_	_	_
22-4	4027-4035	obtained	_	_	_	_
22-5	4036-4038	by	_	_	_	_
22-6	4039-4043	Boyd	person	new	_	_
22-7	4044-4046	et	_	_	_	_
22-8	4047-4050	al.	_	_	_	_
22-9	4051-4052	;	_	_	_	_
22-10	4053-4055	in	_	_	_	_
22-11	4056-4060	this	abstract[226]	new[226]	_	_
22-12	4061-4065	case	abstract[226]	new[226]	_	_
22-13	4066-4067	,	_	_	_	_
22-14	4068-4071	the	person[227]	giv[227]	ana	25-1[0_227]
22-15	4072-4079	authors	person[227]	giv[227]	_	_
22-16	4080-4091	numerically	_	_	_	_
22-17	4092-4101	simulated	_	_	_	_
22-18	4102-4105	the	abstract[229]	giv[229]	ana	23-3[0_229]
22-19	4106-4111	blood	substance|abstract[229]	giv|giv[229]	_	_
22-20	4112-4116	flow	abstract[229]	giv[229]	_	_
22-21	4117-4119	in	abstract[229]	giv[229]	_	_
22-22	4120-4128	ruptured	abstract[229]|object[230]	giv[229]|giv[230]	_	_
22-23	4129-4133	AAAs	abstract[229]|object[230]	giv[229]|giv[230]	_	_
22-24	4134-4136	to	_	_	_	_
22-25	4137-4146	correlate	_	_	_	_
22-26	4147-4152	local	abstract[231]	giv[231]	_	_
22-27	4153-4164	hemodynamic	abstract[231]	giv[231]	_	_
22-28	4165-4172	factors	abstract[231]	giv[231]	_	_
22-29	4173-4177	with	_	_	_	_
22-30	4178-4185	rupture	event|event[233]	giv|new[233]	_	_
22-31	4186-4194	location	event[233]	new[233]	_	_
22-32	4195-4196	.	_	_	_	_

#Text=Nevertheless , it has to be noticed that numerical study may lack of an experimental validation ; to this aim , in vitro modeling have been very useful in the characterization of the complexity implicit in cardiovascular models .
23-1	4197-4209	Nevertheless	_	_	_	_
23-2	4210-4211	,	_	_	_	_
23-3	4212-4214	it	abstract	giv	coref	24-9
23-4	4215-4218	has	_	_	_	_
23-5	4219-4221	to	_	_	_	_
23-6	4222-4224	be	_	_	_	_
23-7	4225-4232	noticed	_	_	_	_
23-8	4233-4237	that	_	_	_	_
23-9	4238-4247	numerical	abstract[235]	new[235]	_	_
23-10	4248-4253	study	abstract[235]	new[235]	_	_
23-11	4254-4257	may	_	_	_	_
23-12	4258-4262	lack	_	_	_	_
23-13	4263-4265	of	_	_	_	_
23-14	4266-4268	an	abstract[236]	new[236]	_	_
23-15	4269-4281	experimental	abstract[236]	new[236]	_	_
23-16	4282-4292	validation	abstract[236]	new[236]	_	_
23-17	4293-4294	;	_	_	_	_
23-18	4295-4297	to	_	_	_	_
23-19	4298-4302	this	event[237]	giv[237]	_	_
23-20	4303-4306	aim	event[237]	giv[237]	_	_
23-21	4307-4308	,	_	_	_	_
23-22	4309-4311	in	_	_	_	_
23-23	4312-4317	vitro	abstract[238]	new[238]	_	_
23-24	4318-4326	modeling	abstract[238]	new[238]	_	_
23-25	4327-4331	have	_	_	_	_
23-26	4332-4336	been	_	_	_	_
23-27	4337-4341	very	_	_	_	_
23-28	4342-4348	useful	_	_	_	_
23-29	4349-4351	in	_	_	_	_
23-30	4352-4355	the	abstract[239]	new[239]	_	_
23-31	4356-4372	characterization	abstract[239]	new[239]	_	_
23-32	4373-4375	of	abstract[239]	new[239]	_	_
23-33	4376-4379	the	abstract[239]	new[239]	_	_
23-34	4380-4390	complexity	abstract[239]|abstract	new[239]|giv	_	_
23-35	4391-4399	implicit	abstract[239]	new[239]	_	_
23-36	4400-4402	in	abstract[239]	new[239]	_	_
23-37	4403-4417	cardiovascular	abstract[239]|abstract|abstract[242]	new[239]|new|giv[242]	_	_
23-38	4418-4424	models	abstract[239]|abstract[242]	new[239]|giv[242]	_	_
23-39	4425-4426	.	_	_	_	_

#Text=In this context , Salsac et al. performed flow measurements using 2D particle image velocimetry ( PIV ) in a rigid and symmetric model of an AAA under pulsatile flow conditions .
24-1	4427-4429	In	_	_	_	_
24-2	4430-4434	this	abstract[243]	new[243]	_	_
24-3	4435-4442	context	abstract[243]	new[243]	_	_
24-4	4443-4444	,	_	_	_	_
24-5	4445-4451	Salsac	person	new	_	_
24-6	4452-4454	et	_	_	_	_
24-7	4455-4458	al.	_	_	_	_
24-8	4459-4468	performed	_	_	_	_
24-9	4469-4473	flow	abstract|abstract[246]	giv|giv[246]	coref|coref|coref|coref	24-30|25-44[269_246]|24-30|25-44[269_246]
24-10	4474-4486	measurements	abstract[246]	giv[246]	_	_
24-11	4487-4492	using	_	_	_	_
24-12	4493-4495	2D	object[248]|object[249]	giv[248]|giv[249]	appos|appos	24-17[0_249]|24-17[0_249]
24-13	4496-4504	particle	object|object[248]|object[249]	giv|giv[248]|giv[249]	_	_
24-14	4505-4510	image	object[248]|object[249]	giv[248]|giv[249]	_	_
24-15	4511-4522	velocimetry	object[249]	giv[249]	_	_
24-16	4523-4524	(	_	_	_	_
24-17	4525-4528	PIV	object	giv	coref	26-28
24-18	4529-4530	)	_	_	_	_
24-19	4531-4533	in	_	_	_	_
24-20	4534-4535	a	abstract[251]	giv[251]	_	_
24-21	4536-4541	rigid	abstract[251]	giv[251]	_	_
24-22	4542-4545	and	abstract[251]	giv[251]	_	_
24-23	4546-4555	symmetric	abstract[251]	giv[251]	_	_
24-24	4556-4561	model	abstract[251]	giv[251]	_	_
24-25	4562-4564	of	abstract[251]	giv[251]	_	_
24-26	4565-4567	an	abstract[251]|organization[252]	giv[251]|giv[252]	coref	26-15[275_252]
24-27	4568-4571	AAA	abstract[251]|organization[252]	giv[251]|giv[252]	_	_
24-28	4572-4577	under	abstract[251]|organization[252]	giv[251]|giv[252]	_	_
24-29	4578-4587	pulsatile	abstract[251]|organization[252]|abstract[254]	giv[251]|giv[252]|giv[254]	_	_
24-30	4588-4592	flow	abstract[251]|organization[252]|abstract|abstract[254]	giv[251]|giv[252]|giv|giv[254]	coref	25-4
24-31	4593-4603	conditions	abstract[251]|organization[252]|abstract[254]	giv[251]|giv[252]|giv[254]	_	_
24-32	4604-4605	.	_	_	_	_

#Text=They investigated the flow pattern and the WSS and WSSG distributions changing the geometric parameters systematically . Stamatopoulos et al. studied both steady and periodic flows in an axisymmetric model of a fusiform aneurism using both computational fluid dynamics ( CFD ) and 2D PIV measurements in the range 100 < Re < 700 .
25-1	4606-4610	They	person	giv	coref	26-3[272_0]
25-2	4611-4623	investigated	_	_	_	_
25-3	4624-4627	the	abstract[257]	giv[257]	_	_
25-4	4628-4632	flow	abstract|abstract[257]	giv|giv[257]	coref	26-11[274_0]
25-5	4633-4640	pattern	abstract[257]	giv[257]	_	_
25-6	4641-4644	and	_	_	_	_
25-7	4645-4648	the	abstract[258]	giv[258]	_	_
25-8	4649-4652	WSS	abstract[258]	giv[258]	_	_
25-9	4653-4656	and	_	_	_	_
25-10	4657-4661	WSSG	abstract|abstract[260]	giv|giv[260]	_	_
25-11	4662-4675	distributions	abstract[260]	giv[260]	_	_
25-12	4676-4684	changing	_	_	_	_
25-13	4685-4688	the	abstract[261]	new[261]	_	_
25-14	4689-4698	geometric	abstract[261]	new[261]	_	_
25-15	4699-4709	parameters	abstract[261]	new[261]	_	_
25-16	4710-4724	systematically	_	_	_	_
25-17	4725-4726	.	_	_	_	_
25-18	4727-4740	Stamatopoulos	person	new	_	_
25-19	4741-4743	et	_	_	_	_
25-20	4744-4747	al.	_	_	_	_
25-21	4748-4755	studied	_	_	_	_
25-22	4756-4760	both	abstract[263]	new[263]	_	_
25-23	4761-4767	steady	abstract[263]	new[263]	_	_
25-24	4768-4771	and	abstract[263]	new[263]	_	_
25-25	4772-4780	periodic	abstract[263]	new[263]	_	_
25-26	4781-4786	flows	abstract[263]	new[263]	_	_
25-27	4787-4789	in	abstract[263]	new[263]	_	_
25-28	4790-4792	an	abstract[263]|object[264]	new[263]|new[264]	_	_
25-29	4793-4805	axisymmetric	abstract[263]|object[264]	new[263]|new[264]	_	_
25-30	4806-4811	model	abstract[263]|object[264]	new[263]|new[264]	_	_
25-31	4812-4814	of	abstract[263]|object[264]	new[263]|new[264]	_	_
25-32	4815-4816	a	abstract[263]|object[264]|object[265]	new[263]|new[264]|new[265]	_	_
25-33	4817-4825	fusiform	abstract[263]|object[264]|object[265]	new[263]|new[264]|new[265]	_	_
25-34	4826-4834	aneurism	abstract[263]|object[264]|object[265]	new[263]|new[264]|new[265]	_	_
25-35	4835-4840	using	_	_	_	_
25-36	4841-4845	both	abstract[267]	giv[267]	coref	25-41[0_267]
25-37	4846-4859	computational	abstract[267]	giv[267]	_	_
25-38	4860-4865	fluid	substance|abstract[267]	giv|giv[267]	_	_
25-39	4866-4874	dynamics	abstract[267]	giv[267]	_	_
25-40	4875-4876	(	_	_	_	_
25-41	4877-4880	CFD	abstract	giv	_	_
25-42	4881-4882	)	_	_	_	_
25-43	4883-4886	and	_	_	_	_
25-44	4887-4889	2D	abstract[269]	giv[269]	_	_
25-45	4890-4893	PIV	abstract[269]	giv[269]	_	_
25-46	4894-4906	measurements	abstract[269]	giv[269]	_	_
25-47	4907-4909	in	abstract[269]	giv[269]	_	_
25-48	4910-4913	the	abstract[269]|abstract[270]	giv[269]|giv[270]	_	_
25-49	4914-4919	range	abstract[269]|abstract[270]	giv[269]|giv[270]	_	_
25-50	4920-4923	100	abstract[269]|abstract[270]	giv[269]|giv[270]	_	_
25-51	4924-4925	<	_	_	_	_
25-52	4926-4928	Re	quantity	giv	_	_
25-53	4929-4930	<	_	_	_	_
25-54	4931-4934	700	_	_	_	_
25-55	4935-4936	.	_	_	_	_

#Text=In , the authors considered a rigid diseased phantom emulating the pulsatile flow in an AAA with aorto-iliac bifurcation and stenosis and measured the flow using 2D PIV .
26-1	4937-4939	In	_	_	_	_
26-2	4940-4941	,	_	_	_	_
26-3	4942-4945	the	person[272]	giv[272]	ana	27-1[0_272]
26-4	4946-4953	authors	person[272]	giv[272]	_	_
26-5	4954-4964	considered	_	_	_	_
26-6	4965-4966	a	person[273]	new[273]	_	_
26-7	4967-4972	rigid	person[273]	new[273]	_	_
26-8	4973-4981	diseased	person[273]	new[273]	_	_
26-9	4982-4989	phantom	person[273]	new[273]	_	_
26-10	4990-4999	emulating	_	_	_	_
26-11	5000-5003	the	abstract[274]	giv[274]	coref	26-24[278_274]
26-12	5004-5013	pulsatile	abstract[274]	giv[274]	_	_
26-13	5014-5018	flow	abstract[274]	giv[274]	_	_
26-14	5019-5021	in	abstract[274]	giv[274]	_	_
26-15	5022-5024	an	abstract[274]|organization[275]	giv[274]|giv[275]	_	_
26-16	5025-5028	AAA	abstract[274]|organization[275]	giv[274]|giv[275]	_	_
26-17	5029-5033	with	abstract[274]|organization[275]	giv[274]|giv[275]	_	_
26-18	5034-5045	aorto-iliac	abstract[274]|organization[275]|abstract[276]	giv[274]|giv[275]|new[276]	_	_
26-19	5046-5057	bifurcation	abstract[274]|organization[275]|abstract[276]	giv[274]|giv[275]|new[276]	_	_
26-20	5058-5061	and	abstract[274]|organization[275]	giv[274]|giv[275]	_	_
26-21	5062-5070	stenosis	abstract[274]|organization[275]|event	giv[274]|giv[275]|new	_	_
26-22	5071-5074	and	_	_	_	_
26-23	5075-5083	measured	_	_	_	_
26-24	5084-5087	the	abstract[278]	giv[278]	_	_
26-25	5088-5092	flow	abstract[278]	giv[278]	_	_
26-26	5093-5098	using	_	_	_	_
26-27	5099-5101	2D	abstract	new	_	_
26-28	5102-5105	PIV	abstract	giv	_	_
26-29	5106-5107	.	_	_	_	_

#Text=They investigated the vorticity field evolution , the vortex core trajectory , and the hemodynamics characteristics .
27-1	5108-5112	They	person	giv	_	_
27-2	5113-5125	investigated	_	_	_	_
27-3	5126-5129	the	abstract[284]	new[284]	_	_
27-4	5130-5139	vorticity	abstract|abstract[284]	new|new[284]	_	_
27-5	5140-5145	field	abstract|abstract[284]	giv|new[284]	_	_
27-6	5146-5155	evolution	abstract[284]	new[284]	_	_
27-7	5156-5157	,	_	_	_	_
27-8	5158-5161	the	abstract[286]	new[286]	_	_
27-9	5162-5168	vortex	abstract|abstract[286]	new|new[286]	_	_
27-10	5169-5173	core	abstract[286]	new[286]	_	_
27-11	5174-5184	trajectory	abstract[286]	new[286]	_	_
27-12	5185-5186	,	_	_	_	_
27-13	5187-5190	and	_	_	_	_
27-14	5191-5194	the	abstract[288]	new[288]	_	_
27-15	5195-5207	hemodynamics	abstract|abstract[288]	giv|new[288]	_	_
27-16	5208-5223	characteristics	abstract[288]	new[288]	_	_
27-17	5224-5225	.	_	_	_	_
